EQS-Ad-hoc: SCHOTT Pharma AG Co. KGaA / Key word(s): Forecast/Change in Forecast

SCHOTT Pharma AG Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin 05-Aug-2025 / 09:53 CET/CEST

Disclosure of an inside information acc. to Article 17 MAR of the…Read More

You might also be interested in reading Strategy Targets Massive Bitcoin Buy With $2.5B Offering Set to Close Within Days.